Research programme: heat shock protein H11 kinase activators - Vasade Biosciences
Latest Information Update: 21 Jul 2016
At a glance
- Originator Vasade Biosciences
- Class Gene therapies; Small molecules
- Mechanism of Action Heat-shock protein stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Ischaemic heart disorders
Most Recent Events
- 21 Jul 2016 Early research in Ischaemic heart disorders in USA (unspecified route)